ClearPoint Neuro (CLPT) Other Accumulated Expenses (2011 - 2026)

ClearPoint Neuro has disclosed Other Accumulated Expenses across 16 years of filings, most recently posting $2.1 million for Q1 2026.

• Other Accumulated Expenses for Q1 2026 came in at $2.1 million, up 40.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.1 million (up 40.73% YoY), and the FY2025 annual result was $2.8 million, up 92.14% from the prior year.
• Other Accumulated Expenses came in at $2.1 million for Q1 2026 at ClearPoint Neuro, down from $2.8 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $2.8 million in Q4 2025 to a low of $602000.0 in Q1 2022.
• The 5-year median for Other Accumulated Expenses is $1.3 million (2024), against an average of $1.4 million.
• Across the five-year window, Other Accumulated Expenses soared 284.54% in 2022 and slumped 49.01% in 2023, its largest moves.
• ClearPoint Neuro's Other Accumulated Expenses stood at $2.1 million in 2022, then sank by 49.01% to $1.1 million in 2023, then soared by 37.7% to $1.4 million in 2024, then soared by 92.14% to $2.8 million in 2025, then decreased by 23.73% to $2.1 million in 2026.
• The last three Other Accumulated Expenses figures came in at $2.1 million (Q1 2026), $2.8 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.